Vongi
ZhiLan Health is a leading Chinese digital healthcare innovation platform focused on data-driven digital therapeutics. It develops and commercializes digital therapy products, including China's first NMPA-certified digital therapy for hepatitis B mother-to-child transmission prevention. The company offers comprehensive services covering R&D, registration, commercialization, clinical research, and data management, leveraging AI and wearable devices to collect physiological and behavioral data. Its SaaS platform and modular development model enable efficient digital therapy product development and full-process health solutions. ZhiLan Health has established a nationwide network of hospitals and experts, conducted large-scale real-world studies with over 40,000 patients, and received multiple national awards and certifications, positioning it as a pioneer in China's digital therapeutics market.
Vongi
ZhiLan Health is a leading Chinese digital healthcare innovation platform focused on data-driven digital therapeutics. It develops and commercializes digital therapy products, including China's first NMPA-certified digital therapy for hepatitis B mother-to-child transmission prevention. The company offers comprehensive services covering R&D, registration, commercialization, clinical research, and data management, leveraging AI and wearable devices to collect physiological and behavioral data. Its SaaS platform and modular development model enable efficient digital therapy product development and full-process health solutions. ZhiLan Health has established a nationwide network of hospitals and experts, conducted large-scale real-world studies with over 40,000 patients, and received multiple national awards and certifications, positioning it as a pioneer in China's digital therapeutics market.